Clinical Trial Update: A Study to Learn How Men With Advanced Prostate Cancer Respond to Treatment With Darolutamide and Hormone Therapy, With or Without Chemotherapy, in Real-world Medical Practice

View source ↗

Summary

A Bayer-sponsored real-world study evaluates how men with advanced, metastatic hormone-sensitive prostate cancer respond to darolutamide in combination with hor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hormone-sensitive Prostate Cancer

Drugs mentioned

• Nubeqa (darolutamide)

Snippet

Sponsor: Bayer | Conditions: Metastatic Hormone-Sensitive Prostate Cancer | Status: ACTIVE_NOT_RECRUITING